Abstract
A review is presented of controlled studies using intensive teaching intervention to improve dyslexics’ reading ability. The results of eight controlled studies reveal only one showing the superiority of teaching. Taking this as a background, the work on Nootropics is reviewed. Both animal and clinical work with Piracetam (the first of the Nootropics) seems to indicate that this medication lacks significant or serious side effects and appears to promote memory and learning. Many double-blind studies of Piracetam have now been conducted on dyslexic children. These studies suggest that Piracetam improves the reading ability of dyslexics. In addition electrophysiological studies support the notion that Piracetam may be “left hemisphere active.” Such encouraging trends will doubtless lead to further research in this interesting area.
Similar content being viewed by others
References
Agnoli, A., Ruggeri, S., Martucci, N., Forchetti, C. and Lazzari, R. 1979. Cognition and Psychomatics.In J. Obiols (ed.).Biological Psychiatry Today (Vol B-2) 867–872.
Antos, S. 1979. Processing facilitation in a lexical decision task.Journal of Experimental Psychology: Human Perception and Performance 5:527–545.
Atanackovic, D., and Simonic, A. 1978. Effect of piracetam (UCB 6215) and dihydroergotamine (DHE) on experimental spinal cord injury. Proceedings of 7e Congress Intern. de Pharmacologie, Paris (France), 16–21 July 1978.
Barcai, A., Umbarger, C., Pierce, T. W. and Chamberlain, P. 1973. A comparison of three group approaches to under-achieving children.American Journal of Orthopsychiatry 43:133–141.
Bradley, L. and Bryant, P. E. 1983. Categorizing sounds and learning to read—a causal connection.Nature 301:419–421.
Bradley, L. and Bryant, P. 1985.Rhyme and Reason in Reading and Spelling. International Academy for Research in Learning Disabilities Monograph Series, Number 1. Ann Arbor: University of Michigan Press.
Bryant, R. C., Petty, F., and Byrne, W. L. 1973. Effects of piracetam (SKF 38462) on acquisition, retention and activity in the goldfish.Psychopharmacologia (Berlin) 29:121–130.
Buresova, O. and Bures, J. 1976. Piracetam-induced facilitation of interhemispheric transfer of visual information in rat.Psychopharmacologia Berlin. 46(1):93–102.
Calliauw, L. and Marchau, M. 1975. Clinical trials of piracetam in disorders of consciousness due to head injury.Acta Anaesthesiologia Belgica 26(1):51–60.
Camp, B. W. and Doorninck, van W. J. 1971. Assessment of “motivated” reading therapy with elementary school children.Behavior Therapy 2:214–222.
Cashdan, A. and Pumfrey, P. D. 1973. Some effects of the remedial teaching of reading.In J. F. Reid (ed.).Reading Problems and Practices. 321–327. London: Ward Lock Educational.
Chase, C. H., Schmitt, R. L., Russell, G., and Tallal, P. 1984. A new chemotherapeutic investigation: Piracetam effects on dyslexia.Annals of Dyslexia 34:29–48.
Collins, J. E. 1961.The Effects of Remedial Education. Educational Monographs no. 4. Birmingham, England: University of Birmingham Institute of Education.
Conners, C. K., Blouin, A., Winglee, M., O’Donnell, D., Smith, A., and Lougee, L. 1984. Piracetam and event-related potentials in dyslexic children.Psychopharmacology Bulletin 20(4):667–673.
Conners, C. K. 1985. Paper delivered at the Thirty-Sixth Annual Conference of The Orton Dyslexia Society. Chicago.
Conners, C. K., Reader, M., Caldwell, J., Clymer, R., Reiss, A., Adesman, A., Caldwell, L., Mayer, L. and Berg, M. 1986. The effects of piracetam upon visual event-related potentials in dyslexic children.Psychophysiology.
DiIanni, M., Wilsher, C. R., Blank, M., Conners, C. K., Chase, C. H., Funkenstein, H. H., Helfgott, E., Holmes, J. M., Lougee, L., Maletta, G. J., Milewski, J., Pirozzolo, F. J., Rudel, R. G. and Tallal, P. 1985. The effects of piracetam in children with dyslexia.Journal of Clinical Psychopharmacology 5:272–278.
Dimond, S. J. 1975. The effects of a nootropic substance on the capacity for verbal memory and learning in normal man. Paper read at 3rd Congress of International College of Psychosomatic Medicine, Rome, Italy. 16–20 September 1975.
Dimond, S. J., and Brouwers, E. Y. M. 1976. Improvement of human memory through the use of drugs.Psychopharmacology 49:307–309.
Dimond, S. J., Scammell, R. E., Pryce, I. G., Huws, D. and Gray, C. 1979. Some effects of piracetam (UCB 6215 Nootropyl) on chronic schizophrenia.Psychopharmacology 64:341–348.
Elliot, C. D., Murray, D. S. and Pearson, L. S. 1978.British Abilities Scales Manual 3: Directions for administration and scoring. Windsor, England: NFER Publishing Co.
Feagans, L. 1985. Paper delivered at the Thirty-Sixth Annual Conference of The Orton Dyslexia Society. Chicago.
File, S. E. and Hyde, J. R. G. 1977. The effects of piracetam on acquisition and retention of habituation.British Journal of Pharmacology 61(3):475.
Gittelman, R. 1983. Treatment of reading disorders.In M. Rutter (ed.).Developmental Neuropsychiatry. New York/London: Guilford Press.
Gittelman, R. and Feingold, I. 1983. Children with reading disorders I. Efficacy of reading remediation.Journal of Child Psychology and Psychiatry 24:167–191.
Giurgea, C. 1972. Vers une pharmacologie de l’activite integrative du cerveau. Tentative du concept nootrope en psychopharmacologie.Actualites pharmacologiques 25e serie, 115–156.
Giurgea, C. 1973. The “nootropic” approach to the pharmacology of the integrative activity of the brain.Conditional Reflex 8(2):108–115.
Giurgea, C. 1979. Nootropic and related drugs interacting with the integrative activity of the brain.In J. Obiols et al. (eds.).Biological Psychiatry Today Vol. B-2, 876–881. Elsevier North, Holland:Biochemical Press.
Giurgea, C. and Mouravieff-Lesuisse, F. 1971a. Effet facilitateur du piracetam sur un apprentissage repetitif.J. de Pharmacol. 2(2):226–227.
Giurgea, C. and Mouravieff-Lesuisse, F. 1971b. Pharmacological studies on an elementary model of learning. The fixation of an experience at spinal level; part I: Pharmacological reactivity of the spinal cord fixation time.Arch. Int. Pharmacodyn et Therap. 191(2):279–291.
Giurgea, C. and Mouravieff-Lesuisse, F. 1972. Effet facilitateur du piracetam sur un apprentissage repetitif chez le rat.J. Pharmacol. 3(1):17–30.
Giurgea, C. and Moyersoons, F. 1970. Differential pharmacological reactivity of three types of cortical evoked potentials.Arch. Int. Pharmacodyn. et Therap. 188(2):401–404.
Giurgea, C., Moyersoons, F., and Evraerd, A. C. 1967. A GABA-related hypothesis on the mechanism of action of the antimotion sickness drugs.Arch. Int. Pharmacodyn. et Therap. 166(1):238–251.
Giurgea, C., and Moyersoons, F. 1972. On the pharmacology of cortical evoked potentials.Arch. Int. Pharmacodyn. et Therap. 199(1):67–78.
Giurgea, C. and Salama, M. 1977. Nootropic Drugs.Progress Neuropsychopharmacol. 1:235–247.
Gouret, C., and Raynaud, G. 1976. Utilisation du test de la boite a deux compartiments pour la recherche de substances protegeant le rat contre l’amnesie par hypoxie; interet et limites de la methode.J. Pharmacol., Paris, 7(2):161–175.
Helfgott, E., Rudel, R. G., and Krieger, J. 1984. Effect of piracetam on the single word and prose reading of dyslexic children.Psychopharmacology Bulletin 20(4):688–690.
Hyde, J. R. G. 1980.Some behavioural and biochemical effects of piracetam: a drug claimed to improve learning and memory. Unpublished PhD thesis, University of London School of Pharmacy.
Jackson, M. D. 1980. Further evidence for a relationship between memory access and reading ability,Journal of Verbal Learning and Verbal Behavior 19:683–694.
Jorm, F. A. 1983. Retardation and working memory: a review.British Journal of Psychology 74:311–342.
Khananashvili, M. M. and Tchubianishvili, L. G. 1982. Research mentionedIn Khananashvili M. M. Pathology of Higher Nervous Activity (Behaviour), publ. in Russian by: Moscou, Ed. Meditzine, p. 286.
Kunneke, P. S. and Malan, G. M. 1979. A controlled clinical trial on the effects of piracetam in epileptic children.British Journal of Clinical Practice 33(9):266–271.
Lagergren, K. and Levander, S. 1974. A double-blind study on the effects of piracetam upon perceptual and psychomotor performance at varied heart rates in patients treated with artificial pacemakers.Psychopharmacologia (Berlin) 39:97–104.
Lefevre, D. 1977.Conditions d’environnement de croissance et modulation de l’inhibition comportementale. Thesis, Louvain University, Belgium.
Lovell, K., Byrne, G. and Richardson, B. 1963. A further study of the educational progress of children who had received remedial education.British Journal of Educational Psychology 33:3–9.
Lovett, M. W., Ransby, M. J., Hardwick, N. and Johns, M. S. 1985. Treatment specific and generalized treatment effects in dyslexic children’s response to remediation. Paper read at the 13th annual meeting of the International Neuropsychological Society San Diego, Feb. 1985. Abstract, The INS Bulletin, November 1984 p23.
Mindus, P., Cronholm, B., Levander, S. E. and Schalling, D. 1976. Piracetam-induced improvement of mental performance: A controlled study on normally aging individuals.Acta. Psychiat. Scand. 54:150–160.
Mindus, P., Isaksson, A. and Wennberg, A. 1981: E. E. G. Findings in patients and volunteers given piracetam, a “Nootropic” drug. Paper presented at 10th International Congress of Electroencephalography and Clinical Neurophysiology, Kyoto, Japan, 13–18 September 1981.
Myslivecek, J. and Hassmannova, J. 1974. An electrophysiological analysis of action of piracetam in rats.Activ. Nerv. Sup., Praha. 16:242–244.
Mysliveckova-Hassmannova, J., Myslivecek, J., and Janda, F. 1978. Learning and memory under the influence of emotional stress and nootropic drug action.Activ. Nerv. Sup. (Praha) 20(4):264–266.
Neale, R. D. 1966.Neale Analysis of Reading Ability. London: Macmillan Education.
Nootropil. 1981. UCB Pharmaceutical Sector, Brussels, Belgium. 4th. ed.
Orton Dyslexia Society, 36th Annual Conference, November 13–16, 1985. Chicago, Illinois. Panel on Piracetam: C. R. Wilsher, M. DiIanni, C. K. Conners, P. Tallal, E. Helfgott, L. Feagans.
Oswald and Lewis, 1972. Quoted as personal communication in “Nootropil” book (UCB).
Overton, 1974. Personal communication to Giurgea, in Giurgea and Salama 1977.
Richardson, J. and Brown, J. 1978. A study of three methods of helping children with reading difficulties.Reading 12(2):10–21.
Rudel, R. G. 1984. Personal communication.
Rudel, R. G. and Helfgott, E. 1984. Effect of piracetam on verbal memory of dyslexic boys.Journal of American Academy of Child Psychiatry 23(6):695–699.
Rudel, R. G. and Helfgott, E. 1985. Paper delivered at the Thirty-Sixth Annual Conference of The Orton Dyslexia Society. Chicago.
Sara, S. J. and David-Remacle, M. 1974. Recovery from electroconvulsive shock-induced amnesia by exposure to the training environment: Pharmacological enhancement by piracetam.Psychopharmacologia (Berlin) 36:59–66.
Sara, S. J. and Lefevre, D. 1972. Hypoxia-induced amnesia in one-trial learning and pharmacological protection by piracetam.Psychopharmacologia 25:32–40.
Sara, S. J., David-Remacle, M., Weyers, M., and Giurgea, C. 1979. Pircetam facilitates retrieval but does not impair extinction of bar-pressing in rats.Psychopharmacology 61:71–75.
Simeon, J. G., Volavka, J., Trites, R., Waters, B., Webster, I., Ferguson, H. B. and Simeon, S. 1983. Electroencephalographic correlates in children with learning disorders treated with piracetam.Psychopharmacology Bulletin 19(4):716–720.
Simeon, J., Waters, B. and Resnick, M. 1980. Effects of piracetam in children with learning disorders.Psychopharmacology Bulletin 16(3):65–66.
Stegink, K. J. 1972. The clinical use of piracetam, a new nootropic drug. The treatment of senile involution.Arzn. Forsch., (Drug research) 22(6):975–977.
Stroesco, V., Gane, P., Granici, A., and Constantinidi, M. 1977. Recherches experimentales sur l’action du piracetam et du pyritinol sur le systeme nerveux central.Rev. roumain Morphol. Embryol. Physiol. Physiologie 14(3):165–172.
Stumpff, 1975. Personal communication to Giurgea, in Giurgea and Salama 1977.
Tallal, P. 1985. Paper delivered at the Thirty-Sixth Annual Conference of The Orton Dyslexia Society. Chicago.
Valame, S. P., Naik, S. R., and Sheth, U. K. 1979. Effect of UCB 6215 on retention of CAR in rat under experimental seizure induced amnesia.Indian J. Med. Res., 69:334–337.
Volavka, J., Simeon, J., Simeon, S., Cho, D., and Reker, D. 1981. Effect of piracetam on EEG spectra of boys with learning disorders.Psychopharmacology 72:185–188.
Wechsler, D. 1976.Wechsler Intelligence Scale for Children—Revised (WISC-R). London: NFER Publishing Company.
Wedl, W. and Suchenwirth, R. M. A. 1977. Effects of the GABA-derivative piracetam: A double-blind study in healthy probands.Nervenarzt 48:58–60.
Wilsher, C. R. 1978.Increasing verbal learning in dyslexic and control subjects using piracetam, (UCB 6215). A. P. Report 87, University of Aston, England.
Wilsher, C. R. 1980. Piracetam treatment of specific written language difficulties (Dyslexia)—A discussion.Dyslexia Review 3(1):8–9.
Wilsher, C. R. 1986. Effects of piracatem on developmental dyslexia.International Journal of Psychophysiology 4(1):29–40.
Wilsher, C. R., Atkins, G. and Manfield, P. 1979. Piracetam as an aid to learning in dyslexia: Preliminary Report.Psychopharmacology 65:107–109.
Wilsher, C. R., Atkins, G. and Manfield, P. 1985. Effect of piracetam on dyslexic’s reading ability.Journal of Learning Disabilities 18(1):19–25.
Wilsher, C. R., and Milewski, J. 1983. Effects of piracetam on dyslexic’s verbal conceptualizing ability.Psychopharmacology Bulletin 19(1):3–4.
Wolthius, O. L. 1971. Experiments with UCB 6215, a drug which enhances acquisition in rats: its effects compared with those of methamphetamineEuropean Journal of Pharmacology 16:283–297.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilsher, C.R. The nootropic concept and dyslexia. Annals of Dyslexia 36, 118–137 (1986). https://doi.org/10.1007/BF02648025
Issue Date:
DOI: https://doi.org/10.1007/BF02648025